Goldman Sachs’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-27,120
| Closed | -$80K | – | 5736 |
|
|
2021
Q3 | $80K | Sell |
27,120
-29,193
| -52% | -$86.1K | ﹤0.01% | 5094 |
|
|
2021
Q2 | $169K | Buy |
56,313
+6,455
| +13% | +$19.4K | ﹤0.01% | 4975 |
|
|
2021
Q1 | $162K | Buy |
49,858
+7,758
| +18% | +$25.2K | ﹤0.01% | 4905 |
|
|
2020
Q4 | $174K | Sell |
42,100
-7,760
| -16% | -$32.1K | ﹤0.01% | 4315 |
|
|
2020
Q3 | $270K | Sell |
49,860
-7,550
| -13% | -$40.9K | ﹤0.01% | 3946 |
|
|
2020
Q2 | $387K | Buy |
57,410
+32,985
| +135% | +$222K | ﹤0.01% | 3715 |
|
|
2020
Q1 | $78K | Buy |
24,425
+2,679
| +12% | +$8.56K | ﹤0.01% | 4210 |
|
|
2019
Q4 | $152K | Buy |
+21,746
| New | +$152K | ﹤0.01% | 4058 |
|
|
2019
Q3 | – | Sell |
-15,691
| Closed | -$60K | – | 4361 |
|
|
2019
Q2 | $60K | Buy |
+15,691
| New | +$60K | ﹤0.01% | 4074 |
|